Janice Chen is the co-founder and chief technology officer of Mammoth Biosciences, a Brisbane, California-based company, founded in 2018, that is developing diagnostic tests using CRISPR.
[3] from the University of California, Berkeley, where she worked in the lab of CRISPR pioneer Jennifer Doudna.
[5] She was also selected to the 2020 Endpoints Top 20 Women in Biopharma,[6] and 35 Innovators Under 35 in MIT Technology Review in 2021.
In 2017, Chen and fellow Berkeley classmate and researcher Lucas Harrington, along with their doctoral advisor, Nobel laureate and Berkeley professor Jennifer Doudna, founded Mammoth Biosciences, a biotech company in San Francisco's Dogpatch neighborhood.
In September 2021, Mammoth—now in a state-of-the-art facility in Brisbane, California—completed its seventh round of funding, raising US$195 million at a valuation of over US$1 billion.